Effective August 1, 2011
Tapentadol (trade name: Nucynta®) will be added to the Triplicate Prescription Program (TPP) Medication List on August 1, 2011.
Revised TPP Medication List
>>
What is tapentadol?
Tapentadol is an opioid analgesic used to treat moderate and chronic nociceptive and neuropathic pain. Approved by Health Canada in December 2010, the drug has been available for use in Canada since March 2011.
Due to its potential for psychological and physical dependence (similar to morphine), Health Canada has included tapentadol as a Schedule 1 drug under the Controlled Substances Act. This should help prevent the potential for trafficking and abuse while allowing its availability for legitimate medical reasons.
